Macrophages derived exosomes deliver miR-223 to epithelial ovarian cancer cells to elicit a chemoresistant phenotype.
Zhu X, Zhu X, Shen H, Yin X, Yang M, Wei H, Chen Q, Feng F, Liu Y, Xu W, Li Y. · 2019
Read Macrophages derived exosomes deliver miR-223 to epithelial ovarian cancer cells to elicit a chemoresistant phenotype. by Zhu X, Zhu X, Shen H, Yin X, Yang M, Wei H, Chen Q, Feng F, Liu Y, Xu W, Li Y. (2019) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc6377760.txt.
Description
Zhu and co-authors present a research article in the Journal of Experimental and Clinical Cancer Research. They studied how macrophages help ovarian cancer resist chemotherapy in low-oxygen tumor zones. Hypoxic cancer cells recruit macrophages and push them toward a tumor-friendly state.
Macrophages under low oxygen packed the microRNA miR-223 into exosomes and passed it to cancer cells. Inside the cancer cells, miR-223 lowered PTEN and switched on the PI3K/AKT pathway, raising drug resistance. The effect held in cell tests and in mouse tumors. Patient samples with high HIF-1 alpha also showed more miR-223. Blood exosome levels tracked with cancer recurrence.
Catalog record
| CREATOR | Zhu X, Zhu X, Shen H, Yin X, Yang M, Wei H, Chen Q, Feng F, Liu Y, Xu W, Li Y. |
|---|---|
| YEAR | 2019 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 59 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |